Sartorius, 1413-050, CellGenix® rh IL-15 (Preclinical Grade)

Top Features for Recombinant Human Interleukin-15:
Optimal use for expansion of MSCs and maintenance of undifferentiated PSCs
ADCF Level 2
High purity to ensure the safety of your process
Available in two different grades (Preclinical and GMP grade)

CellGenix® Recombinant Human Interleukin-15 (IL-15) is an animal-derived component-free product. It is produced in a dedicated animal-free GMP facility. IL-15 is used in the cell and gene therapy space for the ex vivo expansion of various T cells (CAR T cells, TCR T cells and TILs) as well as natural killer cells (NK cells) and the generation of cytokine-induced killer cells (CIK cells).
GMP grade: CellGenix® Recombinant Human IL-15 is produced following all applicable GMP guidelines and allows for the safe use in accordance with USP Chapter <1043>, Ph. Eur. General Chapter 5.2.12 and ISO 20399:2022.
CellGenix® GMP cytokines are provided with documented evidence of purity, potency, consistency and stability. In combination with our expert regulatory and technical support this will help simplify your raw material qualification and validation efforts.
Expiry: ≥ 6 months from date of shipping.
We have submitted Drug Master Files (DMFs) to US Health Authorities to support our customers’ regulatory activities. These Master Files can be cross-referenced through Letters of Authorization (LOAs) in Marketing Authorizations, IND, BLA, NDA, ANDA or other DMF applications. Please submit your Authorization Request via the form above.
Preclinical grade: Designed to meet the demands of translational research, CellGenix® Preclinical cytokines are ideal to bridge the gap between the lower quality of research grade and the higher costs of GMP grade materials.
Expiry: 3 years from date of shipping
For the exact expiry date and the batch specific activity, please refer to the Certificate of Analysis on the My Sartorius Portal.
Safety Data Sheets (SDSs) are available on request.

Specifications
Applications:
Application Area: Cell & gene therapy; Immunology
Cell Type: T Cells; NK Cells; CIK Cells
Intended Use: Preclinical ex vivo use

Biological Information:
Activity: ≥ 8 x 106 IU/mg

Compliance Information:
Origin: Animal-Component Free
Quality Grade: Preclinical

Features:
Carrier-Protein Free: Yes

Physicochemical Information:
Endotoxin: ≤ 0.025 EU/µg
Expression System: E. coli
Formulation: Lyophilized from 200 µL of a 0.2 µm-filtered solution containing 20 mM potassium phosphate, 300 mM sodium chloride and 0.1% polysorbate 20, pH 7.2

Product Information:
Brand: CellGenix®
Package Type: Vial
Size: 50 µg

Sterility/Purity:
Delivery Condition: Sterile
Purity: ≥ 95%

Weight:
Molecular Weight (kDa): 13.7 kDa